$ACRX Up to date company activities and other important

New Post Public Reply Private Reply Replies (0) Message Board
Emylers
$ACRX Up to date company activities and other important information about $ACRX

$ACRX

DD Notes ~ http://www.ddnotesmaker.com/ACRX

##### recent news/filings ~ source: finance.yahoo.com

Thu, 19 Jun 2014 11:00:00 GMT ~ AcelRx Pharmaceuticals to Present at the JMP Securities Healthcare Conference
- REDWOOD CITY, Calif., June 19, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that senior management will present a corporate overview on June 25th. Presentation details are as follows: AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain. AcelRx's lead product candidate, Zalviso™, is designed to improve the management of moderate-to-severe acute pain in adult patients in the hospital setting by utilizing a high therapeutic index opioid, through a non-invasive delivery route via a pre-programmed, patient-controlled analgesia device. AcelRx has announced positive results from each of the three completed Phase 3 clinical trials for Zalviso, and has submitted an NDA to the FDA seeking approval for Zalviso in the treatment of moderate-to-severe acute pain in adult patients in the hospital setting. AcelRx plans to initiate a Phase 3 clinical trial for ARX-04, a product candidate for the treatment of moderate-to-severe acute pain in a medically supervised setting, during the second half of 2014. The company has two additional pain treatment product candidates, ARX-02 and ARX-03, which have completed Phase 2 clinical development. For additional information about AcelRx's clinical programs, please visit www.acelrx.com.
read full: http://finance.yahoo.com/news/acelrx-pharmace...00958.html
*********************************************************

Tue, 17 Jun 2014 13:47:08 GMT ~ AcelRx Pharmaceuticals (ACRX) Jumps: Stock Rises 9.0%
read full: http://finance.yahoo.com/news/acelrx-pharmace...08466.html
*********************************************************

Mon, 16 Jun 2014 20:35:49 GMT ~ ACELRX PHARMACEUTICALS INC Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an Of
read full: http://biz.yahoo.com/e/140616/acrx8-k.html
*********************************************************

Tue, 03 Jun 2014 11:00:00 GMT ~ Results of Cost Analysis Study Presented at ISPOR Meeting Identify Intravenous Patient-Controlled Analgesia (IV PCA) Costs of $200 to $240 for Two Days of Post-Surgical Pain Management
- REDWOOD CITY, Calif., June 3, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced the results of a cost analysis study that showed the use of intravenous patient-controlled analgesia, IV PCA, can typically cost a health system more than $200 in opioid drug and IV PCA equipment costs per patient over a typical 2-day postoperative in-hospital stay. These costs do not include the additional healthcare burden of programming errors and other health risks attributable to IV PCA therapy. The findings are being presented at the 19th Annual International Society for Pharmacoeconomics and Outcomes Research (ISPOR) in Montreal, Canada. Researchers concluded that although IV PCA is a 40-year old technology, the cost of the treatment in the postoperative setting is not insignificant, suggesting that newer, cost-effective solutions are warranted.
read full: http://finance.yahoo.com/news/results-cost-an...00695.html
*********************************************************

Mon, 02 Jun 2014 20:31:19 GMT ~ ACELRX PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers
read full: http://biz.yahoo.com/e/140602/acrx8-k.html
*********************************************************

##### chart ~ source: stockcharts.com

stockcharts.com/c-sc/sc?s=ACRX&p=D&b=5&g=0&id=p95448242713

##### chart ~ source: eoddata.com

http://chart.eoddata.com/?e=OTCBB&s=ACRX&...D&b=BB

##### company info ~ source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/ACRX/company-info
Ticker: $ACRX
OTC Market Place: Not Available
CIK code: not found
Company name: AcelRx Pharmaceuticals, Inc.
Incorporated In:

##### extra dd links

Latest filings: http://www.otcmarkets.com/stock/ACRX/filings
Latest financials: http://www.otcmarkets.com/stock/ACRX/financials
Latest news: http://www.otcmarkets.com/stock/ACRX/news - http://finance.yahoo.com/q/h?s=ACRX+Headlines

Major holdings: http://data.cnbc.com/quotes/ACRX/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=ACRX+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/ACRX.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=ACRX

RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search

DTCC: http://search2.dtcc.com/?q=AcelRx+Pharmaceuti...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&am...als%2C+Inc.
Corporation WIKI: http://www.corporationwiki.com/search/results...=0&y=0

Short Sales: http://www.otcmarkets.com/stock/ACRX/short-sales
Insider Disclosure: http://www.otcmarkets.com/stock/ACRX/insider-transactions
Research Reports: http://www.otcmarkets.com/stock/ACRX/research
Historical Prices: http://finance.yahoo.com/q/hp?s=ACRX+Historical+Prices
Basic Tech. Analysis: http://finance.yahoo.com/q/ta?s=ACRX+Basic+Tech.+Analysis
Company Profile: http://finance.yahoo.com/q/pr?s=ACRX+Profile
Key Statistics: http://finance.yahoo.com/q/ks?s=ACRX+Key+Statistics
Industry: http://finance.yahoo.com/q/in?s=ACRX+Industry
Insider Roster: http://finance.yahoo.com/q/ir?s=ACRX+Insider+Roster
Income Statement: http://finance.yahoo.com/q/is?s=ACRX
Balance Sheet: http://finance.yahoo.com/q/bs?s=ACRX
Cash Flow: http://finance.yahoo.com/q/cf?s=ACRX+Cash+Flow&annual
Market Watch: http://www.marketwatch.com/investing/stock/ACRX
Bloomberg: http://www.bloomberg.com/quote/ACRX:US
Morningstar: http://quotes.morningstar.com/stock/s?t=ACRX
Bussinessweek: http://investing.businessweek.com/research/st...icker=ACRX
Barchart: http://www.barchart.com/quotes/stocks/ACRX
OTC Short Report: http://otcshortreport.com/index.php?index=ACRX
Investopedia: http://www.investopedia.com/markets/stocks/ACRX/?wa=0

http://www.pennystocktweets.com/stocks/profile/ACRX

##### last known share structure ~ source: otcmarkets.com

Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: No Par Value

##### business description ~ source: otcmarkets.com



DD Notes ~ http://www.ddnotesmaker.com/ACRX

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 83

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 314

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 453

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Off-Broadway Play 'DUST' Raises Autism Support Funds

Updated Category News Views 517

Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...

Continue Reading
Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 497

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
2027 Toy of the Year Finalists Energize Play Market

Updated Category News Views 336

A Kaleidoscope of Innovation in Toys There's a familiar buzz in the air, folks. The 2027 Toy of the Year Awards finalists have been unveiled, and they're bringing a fresh wave of creativity to children's playrooms. These aren't just toys; they're miniature innovators ready to light up the market this holiday season. The reveal happened at the Chicago Toy & Game Fair and...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 129

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 564

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 281

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 49

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading

Top 5 Most Recently Viewed Articles

Eric Dane Teams Up with I AM ALS for Urgent Fundraising Efforts

Updated Category News Views 316

Eric Dane Partners with I AM ALS to Drive Change for ALS Actor Eric Dane has joined forces with the national advocacy movement I AM ALS to launch an ambitious campaign called Push for Progress. This initiative seeks to accelerate research for amyotrophic lateral sclerosis (ALS), commonly known as Lou Gehrig's disease, and secure substantial funding to support its...

Continue Reading
CEO Leadership Crisis: Only 9% Show Moral Integrity in 2025

Updated Category News Views 725

Understanding the Leadership Gap: A Call for Moral Integrity New data shows that while the demand for moral leadership is at an all-time high, supply remains critically low. A recent report sheds light on the current landscape of leadership among U.S. CEOs, revealing a concerning trend that only 9% are effectively demonstrating the behaviors associated with moral...

Continue Reading
Experience The Excitement of THE GUNDAM BASE CHICAGO in 2025

Updated Category News Views 281

Introducing THE GUNDAM BASE CHICAGO Exciting news for GUNDAM enthusiasts! Bandai Namco Amusement America (BNAA) is thrilled to announce the opening of THE GUNDAM BASE CHICAGO, slated for winter 2025 at the Fashion Outlets of Chicago. This marks a significant milestone as it's the first permanent location of THE GUNDAM BASE in the United States. A New Era for GUNDAM Fans...

Continue Reading
Two Decades of Atlanta Beltline's Impact on Community Growth

Updated Category News Views 378

Transforming Atlanta: 20 Years of Progress Over the past twenty years, the Atlanta Beltline has emerged as a hallmark of effective urban redevelopment, demonstrating how public investment can transform communities profoundly. With nearly $10 billion in economic impact, it has revitalized neighborhoods, promoted affordable housing, and stimulated small business growth....

Continue Reading
Aptose Biosciences Showcases Promising Progress this Quarter

Updated Category News Views 180

Aptose Biosciences Reports Quarterly Achievements and Financial Updates Aptose Biosciences Inc. (NASDAQ: APTO, TSX: APS), a leading player in clinical-stage precision oncology, has recently shared its outcomes for the third quarter and ongoing developments in their therapeutic initiatives. The company’s mission is centered on innovating targeted oral agents aimed at...

Continue Reading